• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心得安对肝硬化患者的β受体阻滞作用及肝动脉血流量

Beta-blockade with propranolol and hepatic artery blood flow in patients with cirrhosis.

作者信息

Mastai R, Bosch J, Bruix J, Navasa M, Kravetz D, Rodés J

机构信息

Liver Unit, Hospital Clínic i Provincial, University of Barcelona, Spain.

出版信息

Hepatology. 1989 Sep;10(3):269-72. doi: 10.1002/hep.1840100302.

DOI:10.1002/hep.1840100302
PMID:2759544
Abstract

In patients with cirrhosis and portal hypertension, propranolol administration reduces heart rate and cardiac output and diminishes portal pressure and collateral blood flow. However, there is little information on the possible effects of propranolol on hepatic artery blood flow. The present study addressed this question in 12 cirrhotic patients with end-to-side portacaval shunt, in whom all of the liver blood flow represents the hepatic artery blood flow. Hepatic artery blood flow (continuous infusion of indocyanine green), cardiac output (thermal dilution), heart rate and mean arterial pressure were measured before and 20 min after the intravenous infusion of 10 to 15 mg of propranolol. beta-Adrenergic blockade caused a significant reduction of cardiac output (from 9.1 +/- 2.1 to 7.1 +/- 1.4 liters per min, p less than 0.001) (mean +/- S.D.) and heart rate (from 85 +/- 10 to 71 +/- 7 beats per min, p less than 0.001), and a significant increase of systemic vascular resistance (from 9.0 +/- 2.1 to 11.7 +/- 2.7 mmHg per liter per min, p less than 0.001), whereas mean arterial pressure did not change (77 vs. 78 mmHg). Propranolol significantly reduced hepatic artery blood flow (from 0.65 +/- 0.20 to 0.55 +/- 0.14 liters per min, p less than 0.01). However, reduction of hepatic artery blood flow (-12.9 +/- 7.3%) was significantly less than reduction of cardiac output (-21.1 +/- 5.2%, p less than 0.01). As a result, the fraction of the cardiac output delivered to the liver was significantly greater after propranolol (8.0 +/- 1.7%) than before (7.3 +/- 1.7%, p less than 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

在肝硬化和门静脉高压患者中,使用普萘洛尔可降低心率和心输出量,并降低门静脉压力和侧支血流。然而,关于普萘洛尔对肝动脉血流可能产生的影响,相关信息较少。本研究针对12例接受端侧门腔分流术的肝硬化患者探讨了这一问题,在这些患者中,所有肝脏血流均代表肝动脉血流。在静脉输注10至15毫克普萘洛尔之前和之后20分钟,测量肝动脉血流(连续输注吲哚菁绿)、心输出量(热稀释法)、心率和平均动脉压。β受体阻滞剂导致心输出量显著降低(从9.1±2.1升/分钟降至7.1±1.4升/分钟,p<0.001)(平均值±标准差),心率降低(从85±10次/分钟降至71±7次/分钟,p<0.001),全身血管阻力显著增加(从9.0±2.1毫米汞柱/升/分钟增至11.7±2.7毫米汞柱/升/分钟,p<0.001),而平均动脉压未改变(77毫米汞柱对78毫米汞柱)。普萘洛尔显著降低肝动脉血流(从0.65±0.20升/分钟降至0.55±0.14升/分钟,p<0.01)。然而,肝动脉血流的降低幅度(-12.9±7.3%)显著小于心输出量的降低幅度(-21.1±5.2%,p<0.01)。结果,普萘洛尔治疗后输送至肝脏的心输出量比例(8.0±1.7%)显著高于治疗前(7.3±1.7%,p<0.05)。(摘要截断于250字)

相似文献

1
Beta-blockade with propranolol and hepatic artery blood flow in patients with cirrhosis.心得安对肝硬化患者的β受体阻滞作用及肝动脉血流量
Hepatology. 1989 Sep;10(3):269-72. doi: 10.1002/hep.1840100302.
2
Effect of propranolol on hepatic blood flow in patients with cirrhosis.
Clin Pharmacol Ther. 1985 Apr;37(4):376-80. doi: 10.1038/clpt.1985.57.
3
Effects of alpha-adrenergic stimulation and beta-adrenergic blockade on azygos blood flow and splanchnic haemodynamics in patients with cirrhosis.
J Hepatol. 1987 Feb;4(1):71-9. doi: 10.1016/s0168-8278(87)80012-0.
4
Effects of propranolol on azygos venous blood flow and hepatic and systemic hemodynamics in cirrhosis.
Hepatology. 1984 Nov-Dec;4(6):1200-5. doi: 10.1002/hep.1840040617.
5
Effects of propranolol on hepatic haemodynamics in the cirrhotic and non-cirrhotic rat.
Br J Surg. 1985 May;72(5):354-8. doi: 10.1002/bjs.1800720508.
6
Enhancement of portal pressure reduction by the association of isosorbide-5-mononitrate to propranolol administration in patients with cirrhosis.肝硬化患者中,5-单硝酸异山梨酯与普萘洛尔联合使用增强门脉压降低效果。
Hepatology. 1990 Feb;11(2):230-8. doi: 10.1002/hep.1840110212.
7
Continuous prazosin administration in cirrhotic patients: effects on portal hemodynamics and on liver and renal function.肝硬化患者连续服用哌唑嗪:对门静脉血流动力学以及肝脏和肾功能的影响。
Gastroenterology. 1995 Oct;109(4):1257-65. doi: 10.1016/0016-5085(95)90586-3.
8
Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin.生长抑素对肝硬化患者肝脏及全身血流动力学的影响:与血管加压素的比较。
Gastroenterology. 1981 Mar;80(3):518-25.
9
Effects of verapamil on hepatic and systemic hemodynamics and liver function in patients with cirrhosis and portal hypertension.维拉帕米对肝硬化门静脉高压患者肝脏及全身血流动力学和肝功能的影响。
Hepatology. 1988 Jul-Aug;8(4):850-4. doi: 10.1002/hep.1840080425.
10
Effect of beta-adrenergic blockade on elevated arterial compliance and low systemic vascular resistance in cirrhosis.β-肾上腺素能阻滞剂对肝硬化患者动脉顺应性升高和体循环血管阻力降低的影响。
Scand J Gastroenterol. 2001 Jun;36(6):653-7. doi: 10.1080/003655201750163196.

引用本文的文献

1
Adrenoceptors and Hypertension.肾上腺素能受体与高血压。
Handb Exp Pharmacol. 2024;285:297-332. doi: 10.1007/164_2024_719.
2
Assessment of hepatic blood flow in healthy subjects by continuous infusion of indocyanine green.通过持续输注吲哚菁绿评估健康受试者的肝血流量。
Br J Clin Pharmacol. 1991 Dec;32(6):697-704.